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Abstract
Background: Characterization of viruses in HIV-1 transmission pairs will help identify biological determinants of
infectiousness and evaluate candidate interventions to reduce transmission. Although HIV-1 sequencing is frequently used
to substantiate linkage between newly HIV-1 infected individuals and their sexual partners in epidemiologic and forensic
studies, viral sequencing is seldom applied in HIV-1 prevention trials. The Partners in Prevention HSV/HIV Transmission
Study (ClinicalTrials.gov #NCT00194519) was a prospective randomized placebo-controlled trial that enrolled
serodiscordant heterosexual couples to determine the efficacy of genital herpes suppression in reducing HIV-1
transmission; as part of the study analysis, HIV-1 sequences were examined for genetic linkage between seroconverters
and their enrolled partners.
Methodology/Principal Findings: We obtained partial consensus HIV-1 env and gag sequences from blood plasma for 151
transmission pairs and performed deep sequencing of env in some cases. We analyzed sequences with phylogenetic
techniques and developed a Bayesian algorithm to evaluate the probability of linkage. For linkage, we required
monophyletic clustering between enrolled partners’ sequences and a Bayesian posterior probability of $50%. Adjudicators
classified each seroconversion, finding 108 (71.5%) linked, 40 (26.5%) unlinked, and 3 (2.0%) indeterminate transmissions,
with linkage determined by consensus env sequencing in 91 (84%). Male seroconverters had a higher frequency of unlinked
transmissions than female seroconverters. The likelihood of transmission from the enrolled partner was related to time on
study, with increasing numbers of unlinked transmissions occurring after longer observation periods. Finally, baseline viral
load was found to be significantly higher among linked transmitters.
Conclusions/Significance: In this first use of HIV-1 sequencing to establish endpoints in a large clinical trial, more than one-
fourth of transmissions were unlinked to the enrolled partner, illustrating the relevance of these methods in the design of
future HIV-1 prevention trials in serodiscordant couples. A hierarchy of sequencing techniques, analysis methods, and expert
adjudication contributed to the linkage determination process.
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Characteristics of the transmitting and seroconverting partner
affect HIV-1 sexual transmission risk, making studies of HIV-1
serodiscordant couples (in which one partner is HIV-1 infected
and the other is uninfected) of significant scientific value [1].
However, the virus is not bound by vows of fidelity and behavioral
characteristics of sexual partnerships are often difficult to ascertain
due to recall bias and willingness of some persons to report
sensitive behaviors such as concurrent partnerships. HIV-1’s high
mutational capacity has allowed the use of sequencing and
phylogenetic analysis, particularly of the envelope gene [2,3], to
objectively identify HIV-1 source partners and to investigate
patterns of HIV-1 transmission.
Observational studies have used molecular approaches to study
the transmission of HIV-1 from person to person [4,5] and within
populations [6,7]. Forensic investigations of HIV-1 transmission
have also relied upon phylogenetic analysis of HIV-1 sequence
data from suspects and victims [8–11] (reviewed in [12,13]) and
have required the highest burden of proof (‘beyond a reasonable
doubt’) to establish HIV-1 transmission linkage. In contrast, viral
sequence-based linkage determination rarely is applied to HIV-1
prevention trials, since most prevention strategies focus on HIV-
uninfected persons (e.g., vaccines, microbicides or pre-exposure
prophylaxis) in which it is assumed that the efficacy of the
intervention is independent of the source of the transmitted virus.
However, evaluation of interventions aiming to reduce HIV
transmission from infected individuals to their partners require
that each seroconversion event be linked to the source partner, as
the efficacy of such interventions can only be measured if HIV-1
transmission events are definitively linked to a source partner
receiving either the intervention or placebo. Furthermore,
definitive linkage information is important for epidemiologic
studies seeking to quantify the proportion of HIV-1 infections
that could be averted through interventions targeting stable
couples or to characterize risk factors associated with those
transmissions.
An example of such a prevention trial is the Partners in
Prevention HSV-2/HIV-1 Transmission Study that enrolled
African HIV-1 serodiscordant heterosexual couples to evaluate
the efficacy of herpes simplex virus type 2 (HSV-2) suppression
with acyclovir given to HIV-1/HSV-2 dually-infected participants
in reducing HIV-1 transmission to their HIV-1-uninfected
heterosexual partners [14]. Despite the high probability that
HIV-1 strains from couples enrolled in this study would be linked,
the clinical trial demanded that HIV-1 transmission endpoints be
defined systematically. In this paper we report on our evaluation of
genetic linkage between HIV-1 sequences from epidemiologically
linked partnerships in the trial and discuss its potential value for
future studies.
Methods
The Partners in Prevention HSV/HIV Transmission Study
The study design, recruitment, baseline characteristics and
primary study findings of the Partners in Prevention HSV/HIV
Transmission Study are detailed elsewhere [14–16]. Briefly, 3,408
HIV-1 serodiscordant heterosexual couples were enrolled at 14
sites in 7 sub-Saharan African countries. Written, informed
consent was obtained from all participants and the research was
conducted according to the principles in the Declaration of
Helsinki. The University of Washington Human Subjects Review
Committee and ethical review committees at each local and
collaborating organization approved the Partners in Prevention
HSV/HIV Transmission Study protocol and the trial was
registered in ClinicalTrials.gov (#00194519). HIV-1 infected
partners, all of whom were also infected with HSV-2 and 68%
of whom were female, were randomized to either acyclovir
(400 mg orally twice-daily) or placebo and followed for up to 24
months. 155 HIV-1 seroconversions, of which 60% occurred in
couples with females as HIV-1 infected partners, were detected
using rapid and enzyme-linked serologic assays at the local
research sites [15], 151 of which were confirmed by HIV-1
Western blot and quantitative HIV-1 RNA measurements at the
University of Washington [14]. Of these, nineteen seroconverting
partners had negative HIV-1 Western blot but detectable HIV-1
RNA at the time of enrollment (identified by an ‘SC’ in the
partner-pair identifier); these were not included as clinical trial
endpoints due to HIV-1 acquisition at the time of randomization,
but they are included in this report of the linkage analysis. The
primary trial endpoint was defined as incident HIV-1 infection in
a previously HIV-1 uninfected partner (‘seroconverting partner’)
confirmed to be genetically linked to his/her putative transmitting
partner (‘HIV-1 infected partner’) by viral sequence analysis.
Overview of transmission linkage methods
For each putative HIV-1 transmission pair, consensus sequenc-
ing of a population of partial HIV-1 env and gag genes was
performed on blood plasma collected within 3 months of
seroconversion from both partners. This protocol of sequencing
both env and gag was followed with the exception of 12 pairs that
met linkage criteria by env sequencing alone; gag was not sequenced
for these pairs due to time and budgetary constraints. In light of
data showing viral genetic homogeneity in most individuals with
acute/early HIV-1 infection [17–23] it was decided that deeper
sequencing on the HIV-1 infected partner would be performed to
identify potentially low-level transmitted variants in cases of
initially unlinked or indeterminate pairs eligible for inclusion as
trial endpoints. For most pairs (42/49) whose sequences did not
show clear evidence of linkage by env or gag consensus sequencing,
multiple single molecule (SM) C2-V3-C3 env sequences were
obtained following endpoint dilution of cDNA from the HIV-1
infected partner’s plasma to identify linked variants present at
lower frequency. Furthermore, for a subset of unlinked pairs, we
performed env amplicon pyrosequencing of the HIV-1 infected
partner’s virus population to detect even rarer variants that may
have been transmitted. To provide phylogenetic context for the
partners’ HIV-1 sequences we collected publicly available subtype
A, C, and D sequences from African countries, using 1 sequence
per individual, from the Los Alamos National Laboratory HIV
Sequence Database (HIVDB) (http://www.hiv.lanl.gov/content/
sequence/HIV/mainpage.html). To better characterize the HIV
strains circulating in the community at sites with fewer than 10
study-related seroconversions, we obtained env and gag from 3–8
additional HIV-1 infected individuals enrolled at such sites (N=32
across all study sites, shown in Table 1 and Supplementary Table
S1) who were epidemiologically unlinked to the putative
transmission pairs, as a ‘‘local control’’ (LC) comparator
population. This was achieved at all but 1 study site (Site 4). An
adjudication committee of 3 experts, blinded to randomization
arm, independently reviewed sequence data to assign linkage
classification as described below. Supplementary Figure S1 shows
an overview of these laboratory and analysis methods.
Laboratory methods for HIV-1 sequencing
Technicians were blinded to specimen identification and
partnerships. To minimize the risk of specimen mix-up and
contamination, laboratory work on HIV-1 infected and serocon-
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pre-PCR steps were performed in PCR clean rooms. Viral RNA
was extracted from blood plasma using the Qiagen RNA Blood
Mini Kit (Qiagen, Valencia, CA). cDNA was synthesized with
Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA)
and primers RT2 (HXB2 coordinates 3301–3321) and Nef3
(9015–9038). This was followed by nested PCR targeting gag (p17–
p24 region) and envelope (env, C2-V3-C3 region). We used
Expand High Fidelity polymerase (Roche Applied Science,
Indianapolis, IN) and primers gag1 (772–793), RT2 (3301–
3321), ED3 (5957–5986), and Nef3 (9015–9038) for the multi-
plexed first round and Taq polymerase (Invitrogen) and primers
gag2 (793–818), gag5 (1826–1847), ED31 (6817–6845), and ED33
(7360–7381) for the independent second round reactions. Final
sequence lengths were thus ,1,009 base pairs (bp) for gag and
,516 bp for env. For SM sequencing on HIV-1 infected partners’
plasma, we used endpoint serially diluted cDNA to ensure that
PCR amplification of the targeted regions would originate from a
single amplifiable template [24,25]. During the first part of the
study, clonal sequencing of the C2-V5 region of env was performed
for all pairs (PP1-58), using ED31 (6817–6845) and BH2 (7697–
7725) for the first round and DR7 (6990–7021) and DR8 (7638–
7668) for the second round. These amplicons were cloned into
TOPO TA vector (Invitrogen). Given the time and costs of clonal
sequencing for each partner in those first 58 transmission pairs, the
trial endpoint committee decided to utilize consensus sequencing
of partial env and gag regions to increase efficiency in determining
transmission linkage. Both clonal and consensus sequencing was
performed on most of these specimens. For efficiency, this
redundancy on linked pairs was eliminated later in the study.
Plasmid DNA and PCR products were purified with the
FastPlasmid Mini kit (Eppendorf, Westbury, NY) and the
QIAQuick PCR or gel extraction kit (Qiagen), respectively.
Standard dideoxy terminator sequencing was performed at a local
facility. Sequence chromatograms were manually edited with
Sequencher 4.5 (Gene Codes, Ann Arbor, MI). Amplicon
pyrosequencing of C2-V3-C3 env (two, ,220 bp reads from the
59 and 39 ends of the ED31/ED33 env amplicon were obtained
and analyzed separately) was performed on HIV-1 infected
partners’ plasma using the Roche 454 Genome Sequencer FLX
(Roche Diagnostics, Branford, CT). The number of templates
sequenced ranged from 60–2000 per specimen, estimated by
endpoint dilution PCR [24].
Phylogenetic and genetic distance analysis
We screened study sequences against our local laboratory
database and the HIVDB using ViroBLAST [26] (http://indra.
mullins.microbiol.washington.edu/blast/viroblast.php) to identify
specimen mixup or laboratory contamination. Viral subtypes were
determined using REGA 2.0 (http://dbpartners.stanford.edu/
RegaSubtyping/) or the NCBI subtyping tool (http://www.ncbi.
nlm.nih.gov/projects/genotyping/formpage.cgi). In December
2007, we collected all high quality env and gag sequences from
the HIVDB of subtypes A, C, and D from the corresponding gene
regions we sequenced, 1 per subject, and created separate
alignments for subtypes A, C, and D for env (N=172, 250, and
97, respectively by subtype) and gag (N=142, 304, and 90,
respectively) using CLUSTALW [27] or MUSCLE [28], followed
by manual adjustment to optimize codon alignments in Seaview
v3 [29] or MacClade 4.08 [30]. We added each study sequence to
the appropriate alignment, in some cases along with the 5 most
closely related sequences found in the HIVDB. Maximum
likelihood phylogenetic trees and pairwise distances were deter-
mined with the DIVEIN web server [31] (http://indra.mullins.
microbiol.washington.edu/cgi-bin/DIVEIN) using a generalized
time reversible (GTR) model of evolution.
For cases in which pyrosequencing was performed, reads were
initially aligned to an HXB2 reference sequence using Mosaik
[32]. We removed reads containing ambiguous bases and of read
lengths ,100 nucleotides, separated those derived from + and –
strands, and manually trimmed trailing ends to remove poor
quality data. Local realignments were performed using MUSCLE
[28] implemented within the Seaview v3 alignment program [29],
followed by further manual refinement in Seaview. Perl scripts
were written for Mosaik alignment, conversion of. ace files to. fasta
alignments, removal of short reads and those containing N’s,
sorting alignments at their 59 and 39 ends, and determining
pairwise distances to the HIV-1 infected and seroconverter
consensus sequences (scripts available upon request).
Reference datasets
We created two reference sequence datasets from individuals
with known linkage status to establish the distributions of linked
and unlinked env and gag sequence pairs. The ‘‘linked’’ dataset
was derived from sequences from acutely infected individuals and
known transmission pairs. From June 2007- April 2009 when we
conducted our data analysis, the publicly available sequence data
for heterosexual transmission pairs was limited. To augment the
number of sequences in our reference data set, we included data
from individuals with a variety of HIV risk factors, including the
Multicenter AIDS Cohort Study (MACS) [33,34] (acute infec-
tions) as well as from heterosexual [4,35], male-to-male
(unpublished data and [2]), and mother-to-infant [36,37]
transmission cases. Newly available sequences from adjudicator-
confirmed linked partner-pairs from this clinical trial were added
to the dataset following each of the interim adjudications. In total,
sequences from 35/0, 90/57, 117/104, and 147/148 pairs were
obtained in env and gag for the first through final adjudications,
respectively.
The ‘‘unlinked’’ reference dataset was composed of epidemio-
logically unlinked sequences using a dataset composed of
sequences from individuals with no known epidemiologic linkage,
including sequences from the HIVDB and from previously
adjudicated ‘‘unlinked’’ pairs from this study cohort. This
included, in the final analysis, 362/309, 485/474, 186/133
sequences in gag and env from subtype A, C and D, respectively.
Bayesian analysis of genetic distances
We developed a Bayesian algorithm to derive an estimate of the
probability of linkage between sequences in our cohort based on
the reference datasets of pairwise genetic distances for epidemi-
ologically and phylogenetically linked and unlinked individuals
described above. The purpose of the Bayesian analysis was to have
an objective statistical measure of linkage for each HIV-1
transmission event that could account for the prior probability
that HIV-1 sequences from these partner pairs in long-term sexual
partnerships would be linked. According to Bayes’ theorem, the
posterior probability that two sequences are linked (i.e., the
probability of linkage, given existing data) is a function of the prior
probability that they are linked and the distributions of genetic
distances from known linked and unlinked sequences described
above, as shown in the following equation:
P linked X j ðÞ ~
f X linked j ðÞ P linked ðÞ
f X linked j ðÞ P linked ðÞ zf X unlinked j ðÞ P unlinked ðÞ
Establishing HIV-1 Transmission Linkage
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the pairwise genetic distance in this case. P(linked) and
P(unlinked) are the prior probabilities of linkage and lack of
linkage for pairs of sequences from HIV-1 infected partner
participants in our dataset and f(X | linked) and f(X | not linked)
are conditional densities of the genetic distances for linked or
unlinked sequences based on the distribution of genetic distances
in the reference datasets. As opposed to a ‘pure Bayes’ approach
in which an acceptable value or range of values for P(linked) and
P(unlinked) are specified, this approach uses an ‘empirical Bayes’
approach. Here, an initial value of P(linked) is chosen (P(linked)
=0.5), the posterior probabilities of linkage for each couple is
computed, and P(linked) is updated as the proportion of partners
who are classified as linked in the Partners in Prevention HSV/
HIV Transmission Study. This procedure is then iterated until
convergence. Prior to adjudication, Bayesian posterior probabil-
ities were calculated using the distance between the 2 most closely
related sequences in env and gag for each partner pair.
Criteria for assignment of linkage
For each enrolled pair and each level of sequence analysis
(consensus, SM and pyrosequencing), HIV-1 linkage was assigned
by first requiring that partner-pair derived HIV-1 env and/or gag
sequences form monophyletic clusters (i.e., originating from the
same terminal node) in maximum-likelihood phylogenetic trees
that included sequences from unrelated individuals (‘‘local
controls’’). Second, the pairwise genetic distances were required
to be associated with a Bayesian posterior probability $50% for
the gene in which monophyly occurred. Partner-pair sequences
that met these two requirements were tentatively classified as
linked.
An adjudication committee consisting of three independent
experts in HIV-1 viral genetics (J.I.M., F.E.M., and initially T.L.
and subsequently J.A.), who had not participated in the clinical
trial protocol design and were blinded to participants’ treatment
assignments, evaluated phylogenetic and Bayesian posterior
probability for each seroconverter pair. If at least two adjudicators
concordantly assigned linkage status, the pair was tentatively
classified by that assignment. Pairs with linkage status that could
not be determined definitively received indeterminate classifica-
tions. Interim adjudication occurred before each meeting of the
Partners in Prevention HSV/HIV Transmission Study Data and
Safety Monitoring Board and a comprehensive review of the
dataset to finalize linkage assignments by consensus was performed
before the final clinical trial analysis.
Statistical analysis
Selected epidemiologic and biological variables were compared
in linked and unlinked pairs, evaluating for statistical significance
with the two-sided Fisher’s exact test for categorical variables and
Wilcoxon rank sum test for continuous variables.
Results
During The Partners in Prevention HSV/HIV Transmission
Study, 155 incident HIV-1 infections were identified by HIV-1
serology performed at the study site, of which 151 were confirmed
by positive HIV-1 Western blot at University of Washington
(Table 1). The analysis routine we developed is shown in Figure 1,
and a linkage determination flow diagram for the pairs evaluated is
shown in Supplementary Figure S1.
Of the 151 confirmed infections, 108 (71.5%) transmissions
were classified as linked to the HIV-1 infected partner. Linkage
determination was based on consensus HIV-1 env sequence data
for 91 (84.3%), consensus gag sequences for 9 (8.3%), and from
sequencing multiple clones or single molecule-derived amplicons
(SM) env for 8 (7.4%). Forty transmissions (26.5%) were found to
be unlinked and 3 (2.0%) had indeterminate linkage. Overall, 20
linked and 3 unlinked pairs had successful PCR amplification from
only one gene. Of note, we were able to sequence both genes in all
three HIV-1 infected participants (Partners 85A, 122A, and 132A)
who reported antiretroviral therapy use before their partners
seroconverted. Table 1 summarizes final linkage status by site,
with sequence data for each pair and local control participants
(LC) summarized in Supplementary Table S1. Sequences were
submitted to GenBank (accession numbers HQ423670-
HQ424010 and JF293469-JF294997). Phylogenetic trees are
available at (http://www.mullinslab.microbiol.washington.edu/
publications/campbell_2010).
Phylogenetic analysis
Among the 151 pairs, monophyly, defined as uniquely sharing
a most recent common ancestor (MRCA) on the tree, was found
for 84 pairs (55.6%) in both env and gag, but in env only for 16
pairs (10.6%), and in gag only for 9 (6.0%) pairs (Table S1). For
the 25 pairs with linkage in only one gene, phylogenetic
discordance between env and gag was found in only 4 partner
pairs (PP135, SC2, PP133, and PP92) as only one gene was
successfully amplified in the other 21 linked cases. Including the
‘‘local controls’’ (HIV-1 infected individuals from the same
clinical site but not involved in a transmission event), we obtained
Figure 1. Adjudication criteria used in assigning transmission
linkages. For each pair, adjudicators evaluated monophyly (yes/no),
genetic distance, and Bayesian posterior probability ($0.5 or ,0.5) and
classified the pair as ‘linked’, ‘unlinked’, or ‘indeterminate’. Further
evaluation of ‘unlinked’ or ‘indeterminate’ pairs involved gathering
additional data, including sequencing of consensus gag and/or clonal,
single molecule or pyrosequencing of env, as well as obtaining
sequences from non-transmitting HIV-1 infected participants from the
same study site. New trees, distance distributions and Bayesian priors
were generated and each pair was re-adjudicated to make final linkage
assignments.
doi:10.1371/journal.pone.0016986.g001
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study site. No local control sequence was found to split a
monophyletic linkage between enrolled partners. Hence, linkages
were unlikely to be erroneously assigned due to similarity to the
circulating HIV-1 strains at each site. Figure 2 shows examples of
monophyletic and polyphyletic partner pairs and the correspond-
ing distance and Bayesian posterior probability data used for
linkage adjudication.
Genetic distance and Bayesian analysis
The median pairwise genetic distance for linked pairs was 2.8%
(range 0.0–13.0%) in env and 1.3% (range 0.0–9.2%) in gag
(Table 2). In unlinked pairs, median distances were 17.2% (range
11.2–34.6%) and 11.3% (range 6.0–21.6%) in env and gag,
respectively. Distance ranges for linked and unlinked pairs
overlapped due to pairs in which linkage was found in only one
gene, i.e., ranges for the linked pairs included distances for the gene
which was not found to be linked in four cases (PP135, SC2,
PP133, and PP92). Two of the three indeterminate pairs had
genetic distances within the range of partner pairs that were linked
in env (PP92) and gag (PP4 and PP92). However, only one
indeterminate pair (PP92) exceeded the $50% posterior Bayesian
probability cutoff, and in env only. Figure 3 shows the distribution
of env genetic distances for linked and unlinked study pairs
superimposed on the genetic distance distribution for intrasubject
and intersubject linked and unlinked reference data (analogous
data for gag sequences are shown in Supplementary Figure S3).
Median Bayesian posterior probabilities for linked and unlinked
pairs were 99.8% and 1.0% in env and 99.7% and 0.0% in gag,
respectively. 97.2% and 98.1% of linked pairs met the Bayesian
posterior probability cutoff of 50% in env and gag, respectively,
while no unlinked pairs met this criterion (Table 2). As pairwise
distance between couples’ sequences increased, the Bayesian
posterior probability of linkage decreased rapidly, with the
majority of couples’ pairwise distances associated with posterior
probabilities approaching 1 (100% probability of linkage) or 0 (0%
probability of linkage) (Figure 4).
In two instances which were adjudicated as linked (PP47 and
SC1), sequence pairs were monophyletic in env and gag, but with
posterior probabilities ,50% for env (45.8% and 33.0%) but high
for gag (99.4% and 99.9%). In gag, no monophyletic pairs had
posterior probabilities in an intermediate range (Figure 4 and
Figure 2. Examples of Phylogenetically Linked and Unlinked Transmission Events. A section of a phylogenetic tree showing examples of
linked monophyletic (PP73 and PP82) and unlinked polyphyletic (PP45) pairs are shown, along with the adjudication criteria for each.
doi:10.1371/journal.pone.0016986.g002
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were monophyletic in gag with a pairwise genetic distance of 5.8%,
but with a Bayesian posterior probability of ,0%. However, since
SC6’s env sequences met all criteria for linkage, it was classified as
linked. In only one instance (SC2) did Bayesian analysis suggest
linkage (posterior probability of 51.5%) in the absence of
monophyly in the same gene (env). Because gag analysis met both
phylogenetic and Bayesian criteria for linkage, this pair was also
classified as linked.
Deep sequencing (SM and pyrosequencing) for linkage
determination
We evaluated clonal or single molecule (SM) env sequences in 42
pairs that were unlinked or indeterminate by consensus sequencing
with a median of 19 sequences evaluated per HIV-1 infected
participant (range 3–62). Linkage was found in 8 (18.6%), with
linked variants constituting 25–50% of the sequences evaluated for
each linked pair. An example of the use of SM sequencing to
establish linkage for a case (PP17) in which consensus sequences
Figure 3. Pairwise Genetic Distances for env. Distributions of pairwise genetic distances for env reference datasets, within acutely infected
individuals from the Multicenter AIDS Cohort Study at different intervals post infection, between epidemiologically-unlinked pairs of sequences from
the HIVDB of subtypes A, C, and D (lines) and between enrolled partner-pairs from the Partners in Prevention HSV/HIV Transmission Study cohort that
were adjudicated as linked (red bars) and unlinked (blue bars) through sequencing of env, gag, or both. To improve visibility of the data, the y-axis
scale ranges from 0 to 0.25 for bars representing the Partners in Prevention HSV/HIV Transmission Study cohort.
doi:10.1371/journal.pone.0016986.g003
Table 2. Comparison of monophyly, genetic distance, and Bayesian posterior probability results by linkage status and gene.
Criterion Linked (N=108) Unlinked (N=40) Indeterminate (N=3)
env gag env gag env gag
Proportion with Monophyly 0.935 0.880 0 0 0.667 0
Median Pairwise Genetic
Distance (range)
0.028
(0.000–0.130)
0.013
(0.000–0.092)
0.172
(0.112–0.346)
0.113
(0.060–0.216)
0.188
(0.089–0.255)
0.079
(0.068–0.161)
Median Bayesian Posterior
Probability (range)
0.998
(0.038–1.000)
0.997
(0.000–1.000)
,0.001
(0.000–0.271)
0.000
(0.000–0.000)
0.000
(0.000–0.743)
0.000
(0.000–0.000)
Proportion with Bayesian
Posterior Probability $0.50
0.972 0.981 0 0 0.333 0
* Monophyly is defined as sharing the most recent common ancestor on a phylogenetic tree. During evaluation, the adjudicators used the minimum pairwise genetic
distance found between partners’ sequences within each couple and the corresponding Bayesian posterior probability for those most closely related sequence pairs.
The median (range) for genetic distances and Bayesian posterior probabilities displayed in the table reflect the minimum genetic distance and maximum Bayesian
posterior probability for each pair.
doi:10.1371/journal.pone.0016986.t002
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unlinked is shown in Figure 5. In this case, 3 sequences from the
HIV-1 infected partner had distances and Bayesian posterior
probabilities that were categorized as linked to the seroconverter,
whereas 9 other sequences did not meet this criterion. No
relationship was found between classification of a pair as linked
and the number of SM env sequences obtained.
When sufficient numbers of amplifiable viral templates
(N=,50) were available for study, deep resequencing by
pyrosequencing was used to probe for low-level variants. In 11
of 12 unlinked HIV-1 infected partners evaluated, involving a
median of 119 templates per participant, we failed to detect
sequences closely related to that in the seroconverter (Supplemen-
tary Table S2 and Figure S4). In the remaining case (PP9), 3.8% of
the sequence reads from ,61 viral templates from the HIV-1
infected case were closely related to viruses found in the
seroconverter (Supplementary Table S1).
Viral subtype
HIV-1 subtype was determined for both env and gag sequences
(Tables 1 and S1) from each partner pair. In both genes,
participants’ viruses were predominantly subtype A or C (43%
each in env, 44% and 36% in gag, respectively), with 13% of the env
sequences and 10% of the gag sequences found to be subtype D.
One subtype G infected pair was detected, and 2% of the env and
10% of the gag sequences were intersubtype recombinants. Among
the 128 partner pairs with sequences determined for both env and
gag, 13 pairs (10.1%) had different subtypes in env compared to gag
genes, suggesting the presence of additional intersubtype recom-
binant viruses. In an additional 13 couples (4 linked, 6 unlinked,
and 3 indeterminate pairs) discordant subtypes were identified
between env and gag sequences in one partner, without such a
discrepancy in the other partner.
When stratified by subtype, no statistically significant difference
in the frequency of linked and unlinked pairs was found.
Specifically, among linked transmissions, 69.8%, 66.7%, and
73.7% of env sequences, were subtype A, C, and D, respectively.
The proportions of each subtype among linked transmissions were
almost identical for gag sequences. Among intersubtype recombi-
nants, 84.6% (11/13) were classified as linked.
Discordant linkage findings
Eighty-four (95.5%) linked pairs having env and gag sequences
met criteria for linkage in both genes. Among those classified as
linked, two (2.3%) pairs met criteria for linkage in gag only (PP135
and SC2); and one (1.1%) pair met criteria for linkage in env only
(PP133). The seroconverters in these 3 couples may have been
infected by more than one HIV-1 strain. Eleven (7%) pairs had env
and gag sequences of different subtypes, 2 from Zambia, 5 from
Kenya and 4 from Uganda. Of these, 4 were classified as linked,
with concordant env and gag subtypes between partners, suggesting
that a virus with a recombinant subtype may have been
transmitted from the HIV-1 infected partner to the seroconverter.
In the remaining 7 pairs, 1 indeterminate and 6 unlinked, each
partner’s virus had a different mosaic subtype pattern.
Adjudicator agreement and indeterminate pairs
During the 3 interim meetings, 3 HIV-1 sequencing experts
reviewed available data and gave recommendations for pairs that
required additional sequencing and analysis before their linkage
Figure 4. Bayesian Posterior Probabilities for env and gag Datasets. Plot showing relationship between Bayesian posterior probabilities and
genetic distance between partner pairs from the Partners in Prevention HSV/HIV Transmission Study cohort in env and gag.
doi:10.1371/journal.pone.0016986.g004
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data from all transmission pairs were reviewed by the adjudication
committee. Complete agreement was reached between adjudica-
tors’ classification of all linked and unlinked pairs. Six (3.9%) pairs
required discussion before all 3 adjudicators determined they were
linked at the final adjudication meeting. Discussions focused on
clarification of sequence labeling on phylogenetic trees and close
inspection of phylogenies and pairwise distances in cases where
deep sequencing had been performed. Adjudicators were unable
to determine the linkage status of 3 pairs, described below, in
which sequencing was completed (Supplementary Table S1).
Two pairs’ data (PP4 and PP9) were suggestive of linkage in env
only. PP4’s consensus env and gag sequences were polyphyletic,
with distances and Bayesian posterior probabilities outside the
expected range for linked transmissions (Table S1). The viral
subtype in env was C for the female HIV-1 infected participant and
A for her male seroconverting partner. After SM env sequencing, 1
of 17 sequences from the HIV-1 infected participant was found to
be of subtype A and fell in a monophyletic cluster with the
seroconverter’s sequences. However, the subtype A env sequence’s
pairwise genetic distance (18.8%) and Bayesian posterior proba-
bility (0.0%) were inconsistent with linkage, as was gag data, so Pair
4 was categorized as indeterminate.
Similarly, consensus env sequences from the female HIV-1
infected and male seroconverting partners of PP9 were of different
subtypes (C and A, respectively). Both consensus env and gag
sequences were polyphyletic and with large distances (25.5 and
16.1%, respectively). SM env sequencing from both participants
(N=16 and 29, respectively) did not reveal any more closely
related sequences. However, approximately 61 env templates from
the HIV-1 infected participant were subjected to pyrosequencing,
which did reveal a variant that was closely related to the
seroconverting partner’s virus, comprising 3.8% of the viral
population on the 39 ends of the amplicon, with no close relatives
above the 100 nt cutoff read length from the 59 end reads (4 short
reads, corresponding to 0.2% of the total sequences were found to
be related to the seroconverter consensus but were discarded due
to poor quality). The adjudication team concluded that the small
fraction of related sequences found by a sequencing technique that
is still in development for applications related to HIV-1 evolution
did not provide sufficient evidence to categorize this pair as linked.
Finally, PP92’s consensus env sequences were monophyletic, but
with a large pairwise distance of 8.9%. After consensus gag
sequences were found to be polyphyletic and relatively distant
(6.8%) and 17 SM env sequences from the HIV-1 infected partner
did not reveal a sequence with a smaller genetic distance to the
serooconverter’s virus, this pair was also classified as indetermi-
nate.
Epidemiologic support for linkage assignments
We compared demographic and clinical characteristics of
linked and unlinked partnerships to examine their associations
with linkage (Table 3). The seroconverting partner was male in
88 (58.3%) and female in 63 (41.7%) of the 151 couples,
reflecting, in part, the study enrollment gender distribution with
67% of enrolled partners being male. However, seroconverters
were female in a larger proportion of linked relative to unlinked
pairs (46.3% versus 27.5%, p=0.04). The timing of seroconver-
Figure 5. Examples of HIV-1 Transmission Classified as Linked by SM Sequencing. Example of a pair (Pair 17) whose consensus env
sequences were unlinked, with linkage subsequently determined by single molecule (SM) env sequences. The linkage criteria used during
adjudication are displayed in the table. Three linked sequences from the HIV-1 infected partner, PP17A variant 1, along with the sequences from the
seroconverting partner PP17B are bounded by the solid rectangle. Unlinked sequences from the HIV-1 infected partner, PP17A variant 2 are
delineated by the dotted rectangle.
doi:10.1371/journal.pone.0016986.g005
Establishing HIV-1 Transmission Linkage
PLoS ONE | www.plosone.org 9 March 2011 | Volume 6 | Issue 3 | e16986sion also was associated with linkage, with linked pairs having a
shorter average time to seroconversion than unlinked pairs (6
versus 12 months after enrollment, p=0.001). Furthermore, there
was a trend toward the proportion of linked transmissions being
greater among seroconversions identified at the first 3-month
study visit compared to seroconversions identified after 3 months
(89.5% versus 66.9%, p=0.06). Sexual activity with the HIV-1
infected partner at the 3-month study visit prior to seroconversion
was reported more commonly by linked than unlinked serocon-
verters (87% versus 70%, p=0.027). Conversely, sex with
partners other than the HIV-infected partner with whom they
enrolled was reported more commonly by unlinked than linked
seroconverters (30% versus 1.9%, p,0.001) and the majority of
these unlinked partners were male. Finally, baseline plasma HIV-
1 RNA levels for the HIV-1 infected partner were higher among
linked pairs than unlinked pairs (4.7 versus 4.0 log10 copies/ml,
p,0.001).
Discussion
We conducted an evaluation of HIV-1 transmission linkage by
analysis of phylogenetic and genetic distance data and Bayesian
posterior probabilities among HIV-1 seroconverters who were
followed prospectively in a cohort of east and southern African
HIV-1 serodiscordant couples. Through a hierarchical, multi-step
process based on sequencing, phylogenetic and Bayesian statistical
analysis, and independent adjudication, we found that over one
quarter (26.5%) of HIV-1 transmission events within this cohort
were not linked to the enrolled partner.
Numerous studies have used viral sequencing to evaluate HIV-1
transmission linkage, but our analysis represents the first use of
viral sequencing for HIV-1 transmission linkage as an integral
component in the primary efficacy analysis of a large randomized
HIV-1 prevention trial. Because the trial’s intervention was
intended to reduce infectiousness in the HIV-1 infected partner,
only linked transmissions were relevant to ascertainment its
efficacy. As with previous linkage assessments in observational
studies [35], our protocol (Figure 1 and Table 4) included an
evaluation of sequence data from env and gag for monophyly in
maximum likelihood trees to determine linkage. However, to
provide additional statistical support for our linkage determina-
tions, we developed a Bayesian algorithm incorporating prior
probability of linkage and genetic distance data and increased our
sensitivity for detecting rare variants in the HIV-1 infected partner
that may have been transmitted to the seroconverter using deep
sequencing techniques. While consensus env sequencing identified
85% of linked pairs, gag and deep env sequencing permitted
classification of an additional 9 (8.3%) and 8 (7.4%) linked pairs,
respectively, that would not have been linked if only consensus env
were used to define linkage. Our Bayesian algorithm provides a
quantitative assessment of linkage and offers additional perspective
for the genetic distance data, by relating those data to the expected
distance ranges for linked and unlinked sequence pairs. It did not,
however, take precedence over phylogenetic linkage determina-
tions. In 3 pairs (PP47, SC1, and SC6), linkage decisions were
based on monophyly despite having Bayesian posterior probabil-
ities ,50%. In future studies, if a particular site lacked ’’local
controls’’ or other geographically-appropriate reference sequences,
Table 3. Association of demographic and clinical factors with linkage.
All Pairs
(N=155)
Linked Pairs
(N=108)
Unlinked Pairs
(N=40) p value
*
Gender
Seroconverting partner female 64 (41.3%) 50 (46.3%) 11 (27.5%) 0.041
Median age at enrollment (range)
Seroconverting partner 30 (26–38) 30 (25–38) 32 (26–36) 0.425
HIV-1 infected partner 31 (25–37) 30.5 (26–36) 31 (25–39.5) 0.935
Time to seroconversion
Identified at 3 month visit 19 (12.3%) 17 (15.7%) 2 (5.0%) 0.101
Months of follow-up before seroconversion 9 (3–15) 6 (3–15) 12 (9–17) 0.001
Study site location
East Africa 96 (61.9%) 68 (63.0%) 23 (57.5%) 0.572
Southern Africa 59 (38.1%) 40 (37.0%) 17 (42.4%) 0.572
Behavioral characteristics of seroconverting
partner prior to seroconversion
Reported sex with HIV-1 infected partner
t 127 (81.9%) 94 (87.0%) 28 (70.0%) 0.027
Reported sex with a non-enrolled partner
t 14 (9.0%) 2 (1.9%) 12 (30.0%) ,0.001
Female 3 (4.7%) 1 (2.0%) 2 (18.2%) 0.081
Male 11 (12.1%) 1 (1.7%) 10 (34.5%) ,0.001
Characteristics of HIV-1 infected partner
Enrollment plasma HIV-1 RNA (log10 copies/mL) 4.6 (4.0–5.1) 4.7 (4.3–5.1) 4.0 (3.5–4.8) ,0.001
CD4 count (cells/uL) at visit closest to seroconversion 379 (281–506) 364 (255-495) 369 (307-502) 0.323
Reported use of antiretroviral therapy at visit prior
to seroconversion
3 (1.9%) 1 (0.9%) 2 (5.0%) 0.178
Comparison of linked and unlinked transmission pairs.
tCalculated for each 3 month period of observation.
doi:10.1371/journal.pone.0016986.t003
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monophyletic pairs associated with transmission versus those that
were more genetically distant, yet clustered due to geographic
location. The determination of linkage by individual adjudicators
was highly consistent, with identical independent assessments in
96% of cases, followed by full concurrence after discussion. If only
one scientist had evaluated the data, 6 (5.6%) of the linked pairs
may have received an indeterminate designation, which suggests
that discussion amongst experts during the adjudication process
was helpful in resolving uncertainties in interpretation of the data.
In only 3 (2.0%) of cases were adjudicators unable to determine
the linkage status conclusively, possibly due to HIV-1 dual or
superinfection followed by recombination of viral strains. Addi-
tional deep or whole genome sequencing may resolve such
indeterminate classifications, but was beyond the scope of this
study.
The majority of linked and unlinked pairs were clearly
separated by phylogenetic relationships, genetic distance, and
Bayesian posterior probability estimates, allowing adjudicators
to definitively classify transmission linkage for 98% (148/151)
of putative transmission events. Our finding that ,27%
of seroconverters’ HIV-1 sequences were unlinked to those of
their enrolled partners underscores that transmission linkage
cannot be assumed, and in doing so, provides a guide to
help minimize uncertainty in HIV-1 transmission linkage
assignment for future observational studies of HIV-1 infectiousness
and trials of candidate prevention interventions to reduce HIV-1
infectiousness.
Nevertheless, several limitations are noteworthy. First, we could
not determine the relative utility of each type of sequencing in
linkage determination because our protocol did not require all
three types of sequencing data from each individual, but we
advocate for use of consensus env sequencing at a minimum, as
85% of linked pairs were determined by analysis of partial
consensus env sequences, followed by consensus gag and multiple
env variant sequencing, as needed. Second, our ability to sequence
‘‘local controls’’ from each study site was also limited. Ideally, we
would have sequenced a robust sample of the circulating viral
population from epidemiologically unlinked individuals that
corresponded to the HIV-1 subtype found in participants at each
study site. However, when we received participants’ plasma
specimens, the viral subtypes were unknown and the clinical trial’s
Table 4. Summary of sequencing and analysis methods used in this study.
Benefits Limitations Impact on this study
Data type
Consensus env -C2-V3-C3 region captures variation in
env and lacks large insertions and deletions
found in other regions of the gene
-Large number of sequences in HIVDB
-Only reveals variant that comprises
majority of plasma viruses
-84.3% (91/108) pairs
linked by consensus env
Consensus gag -p17 and p24 regions contain
variable areas within gag
-Longer sequence than consensus env
-Only reveals variant that comprises
majority of plasma viruses
-Less variable than env and fewer
published sequences in HIVDB
-8.3% (9/108) additional pairs
linked only by consensus gag
Single molecule (SM) env -Improves sampling of circulating
plasma viruses to better capture
variants within an individual
-Requires more laboratory
effort than consensus sequencing
-Performed for 27.8% (42/151) of pairs
that were unlinked or indeterminate by
consensus sequencing, with 7.4% (8/108)
additional pairs linked only by SM env
env pyrosequencing -Facilitates sampling larger number
of viruses compared to SM
-Computational challenges
in data analysis
-Performed for 7.9% (12/151) of pairs
that were unlinked by consensus, but
did not lead to more pairs linked and
adjudicators questioned reliability of data
Analysis method
Phylogenetic tree -Shows relationships between
multiple sequences
-Relationships between sequences
are contextual and depend upon
the relatedness of all sequences in
the phylogeny, i.e., additional ‘‘local
control’’ sequences are valuable as
they can disrupt fortuitous
monophyletic relationships
-Sequences from all linked pairs were
monophyletic in env, gag, or both and
sequences from unlinked pairs were
polyphyletic in both genes
-Indeterminate pairs had suggestion
of linkage in env, but not in gag
Pairwise genetic distance -Numerical result that compares
the differences between each
nucleotide in 2 sequences
-Viruses within transmitters can
have wide genetic variation and
thus it is not possible to set an
a priori cutoff value for linkage
-Clear difference in median distances in
linked and unlinked pairs, but distance
ranges overlapped due to pairs that were
linked in 1 gene but not the other
Bayesian posterior
probability
-Estimates the probability that the
genetic distance between sequences
from a putative HIV-1 transmission pair
represents a within-couple transmission
-Relies on reference data for
epidemiologically linked and
unlinked HIV-1 infected individuals
-Median posterior probabilities for
linked and unlinked pairs approached
100% and 0%, respectively
-Posterior probability $50% in only 1 pair
whose env sequences were polyphyletic
Expert adjudication -Provides a forum for resolving
uncertainties in data interpretation
-Reduces potential for subjectivity
and error in linkage determination
-Requires multiple scientists’
time/effort
-Discussions at interim meetings guided
further sequencing efforts
-Experts agreed on all final classifications
of linked and unlinked pairs and were
unable to classify only 2% (3/151) of pairs
doi:10.1371/journal.pone.0016986.t004
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participants. We found that the subtype A, C, and D sequences
from Africa retrieved from the HIVDB adequately separated the
sequences from sites in our study, minimizing the possibility that
geographic clustering led to false evidence of linkage. Finally, the
epidemiologically linked reference sequence data sets used to
develop the Bayesian algorithm were not taken exclusively from
transmission pairs whose HIV-1 risk factor was heterosexual sex.
There were few publicly available sequences from genetically
linked heterosexual HIV-1 transmissions and we therefore needed
to include data from male-male and mother-infant transmission
pairs. However, as the trial proceeded, sequence pairs that the
adjudicators determined to be linked were added to this database,
such that the data from linked pairs in our trial outnumbered those
from published reference sets.
Recent data has revealed the role of minority viral variants from
the transmitting partner in individuals acquiring HIV-1 through
heterosexual sex [22,38,39], which was our rationale for using
deep sequencing techniques in couples whose viruses were initially
found to be unlinked. An additional step that could have been
performed was analysis of HIV-1 sequences from genital
specimens of HIV-1 infected partners. Although it is theoretically
possible that sequencing from blood may have missed a viral
variant present exclusively in a genital compartment, the
likelihood of this is low, as analyses of seminal and cervicovaginal
specimens have shown that viral sequences from blood and genital
sites cluster monophyletically and often intermingle within an
individual [40–42].
The relatively high fraction (26.5%) of unlinked infections we
found differs from a cohort study of HIV-1 serodiscordant couples
in Zambia from 1994-2000, in which 13% of prospectively
identified seroconverters were found to have viruses not linked to
their stable partner [35]. Their study used analogous laboratory
methods, involving amplification of HIV-1 env and gag consensus
sequences from blood plasma RNA, and similarly evaluated
phylogenetic relationships and genetic distances. While the two
studies cannot be directly compared due to differences in design,
location, and period of conduct, it is notable that a greater
proportion of HIV-1 infected partners in the Zambian cohort were
male compared to our cohort (52% versus 33%). In our study,
male seroconverters were significantly more likely than females to
report sex with additional partners; it is plausible that the greater
proportion of male seroconverters with unlinked viruses is a
consequence of this behavior and may explain the higher rate of
unlinked infections our cohort. Our finding of more unlinked
seroconversions occurring later after study enrollment most likely
is related to the increase in reported sexual activity with partners
other than those with whom they were enrolled during the 2 years
of follow-up [14]. The strong associations we saw between
unlinked transmission and reported sexual activity with additional
partners and the higher proportion of female seroconverters found
to be infected from their stated partners, corroborates our linkage
assignments and suggest that behavioral rather than biological
factors may underlie the higher rate of non-linkage in our cohort.
Our rigorous evaluation of transmission linkage reduced potential
misclassification of over a quarter of seroconversion endpoints – a
substantial issue for efficacy trials of interventions to reduce HIV-1
infectiousness. Insofar as the unlinked transmissions represent
HIV-1 infection transmitted from outside the stable HIV-1
serodiscordant partnership, our findings underscore the impor-
tance of incorporating messages that underscore the risk of sex
with partners of unknown serostatus when working with HIV-1
serodiscordant couples. In addition, our finding of nearly 30% of
HIV-1 transmissions being genetically unlinked and likely
acquired from an outside partner in these African couples,
indicates a need for biomedical interventions, such as vaccines,
microbicides and pre-exposure prophylaxis, for the HIV-1
seronegative partner in serodiscordant partnerships.
The Partners in Prevention HSV/HIV Transmission Study did
not find an association of HSV-2 suppression with a change in
HIV-1 transmission through either a modified intent-to-treat
analysis evaluating only linked HIV-1 transmission events, or a
per-protocol-analysis that evaluated all eligible HIV-1 transmis-
sion events [14]. However, for future studies, the erroneous
assumption of linkage for one quarter of identified transmission
events could clearly be a major source of misclassification bias with
a consequent high risk of inaccurate conclusions about risk factors
for HIV-1 transmission or efficacy of interventions to reduce HIV-
1 infectiousness. While the need for deep sequencing in future
HIV-1 transmission linkage confirmation algorithms bears further
study, our findings suggest that analysis of HIV-1 sequences from
two potentially linked individuals in a clinical trial should include:
1) consensus env, 2) consensus gag, 3) analysis for monophyly and
pairwise genetic distance in both gene regions, 4) Bayesian
posterior probability calculations incorporating the prior proba-
bility of linkage and the pairwise genetic distances, 5) discussion/
adjudication by experts, and 6) sequencing of multiple env variants
in putative transmitting partners in couples without clear evidence
of linkage by consensus sequencing. Our approach is relevant both
for future HIV-1 prevention trials evaluating interventions that
target the HIV-1 infected partner and for studies seeking to
characterize virologic, immunologic, and host genetic determi-
nants of HIV-1 transmission.
Supporting Information
Figure S1 Overview of Laboratory and Analysis Meth-
ods. (a) Overview of laboratory methods. RNA was extracted
from blood plasma, cDNA synthesized, and multiplex PCR
targeting env and gag was performed. Sequences were aligned and
analyzed in the context of reference and ‘local control’ sequences
of the same subtype. Phylogenetic relationships, pairwise genetic
distances, and Bayesian posterior probabilities were obtained. (b)
Process by which posterior probabilities of linkage were obtained.
The linked dataset corresponded to sequences derived from the
Los Alamos National Laboratory HIV database (HIVDB) and
trimmed to match the amplicons sequenced in the current study in
env and gag. The linked dataset was composed of intrasubject
sequences from ,2 years after infection from the MACS, from
available linked partner pairs from the literature and intermediate
adjudications in this study, and from mother-infant transmission
pairs. Three unlinked datasets were initially derived, from HIV-1
subtypes A, B and C, one sequence per subject and from
individuals with no known epidemiologic linkage. After each set
of sequences were aligned, pairwise distances were determined
and the each dataset combined to create one ‘‘linked’ and one
‘‘unlinked’’ pairwise distance dataset. Alignments are available
at (http://www.mullinslab.microbiol.washington.edu/publications/
campbell_2010). These datasets were used to estimate prior
probabilities of linkage using the Bayesian approach described in
Methods.
(PPT)
Figure S2 Linkage Results Flow Chart. Flow chart of
sequences obtained and linkage results for all pairs evaluated.
*Consensus gag sequence analysis contributed 5 linkages in eligible
pairs and 4 linkages in 3-month seroconverters (circles) over
consensus env sequencing alone. Deep sequencing by clonal or
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revealed 8 additional linked pairs. Deep sequencing was not
performed in 3-month seroconverter pairs, as they were not
included in the modified intention to treat analysis.
(TIF)
Figure S3 Pairwise Genetic Distances for Reference gag
Datasets. Distributions of pairwise genetic distances for gag
reference datasets and between enrolled partner-pairs from the
Partners in Prevention HSV/HIV Transmission Study cohort that
were adjudicated as linked (red bars) and unlinked (blue bars)
through sequencing of env, gag, or both.
(TIF)
Figure S4 Pyrosequencing Analysis. Each panel shows the
distribution of pairwise genetic distances between a reference
sequence (the consensus of env sequences from each seroconverting
partner) and pyrosequences derived from the index partner. See
Supplementary Table S2 for details. The graph on the left side of
each panel shows the analysis of the 59 and 39 reads, respectively.
Distributions marked in blue indicate the relationship of the HIV-
1 infected partners’ sequences to the consensus of the serocon-
verting partners’ sequence. Distributions marked in red indicate
the relationship of seroconverting partners’ sequences to the
consensus of the HIV-1 infected partners’ sequence.
(PPT)
Table S1 Summary of HIV-1 Transmission Linkage and
Local Control Sequence Data. Demographic, sequence, and
linkage data for each couple and ‘‘local control’’ participant.
Pairwise nucleotide distances shown are the smallest pairwise
distances obtained, from either consensus or single molecule
sequencing in env or consensus sequencing in gag, with Bayesian
posterior probabilities corresponding to the distances shown.
(XLS)
Table S2 Summary of HIV-1 env Pyrosequencing Anal-
ysis. Pyrosequencing analysis of the HIV-1 infected partner’s env
sequences in pairs of individuals without prior evidence of linkage.
The approximate number of templates evaluated in each
pyrosequencing reaction are shown, along with the number of
raw and final reads used in the evaluation. 400 bp amplicons were
sequenced using primers from the 59 and 39 ends. The ,220 bp
reads from each end were analyzed separately. A variable number
of sequences were removed from the final alignments as described
in the Methods. Pyrosequencing on the thirteenth pair listed,
PP118, did not yield sequence data due to insufficient read length.
(TIFF)
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